Avai Bio (AVAI) Current Assets (2018 - 2023)
Avai Bio's Current Assets history spans 5 years, with the latest figure at $38047.0 for Q4 2023.
- For Q4 2023, Current Assets fell 74.15% year-over-year to $38047.0; the TTM value through Dec 2023 reached $38047.0, down 74.15%, while the annual FY2023 figure was $107575.0, N/A changed from the prior year.
- Current Assets for Q4 2023 was $38047.0 at Avai Bio, up from $1594.0 in the prior quarter.
- Across five years, Current Assets topped out at $620293.0 in Q3 2020 and bottomed at $239.0 in Q2 2019.
- The 4-year median for Current Assets is $107575.0 (2023), against an average of $151365.8.
- The largest annual shift saw Current Assets surged 103776.99% in 2020 before it crashed 99.74% in 2023.
- A 4-year view of Current Assets shows it stood at $8672.0 in 2019, then soared by 4331.75% to $384321.0 in 2020, then tumbled by 61.7% to $147180.0 in 2022, then crashed by 74.15% to $38047.0 in 2023.
- Per Business Quant, the three most recent readings for AVAI's Current Assets are $38047.0 (Q4 2023), $1594.0 (Q3 2023), and $635.0 (Q2 2023).